Medtronic
649
61
97
375
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.9%
77 terminated/withdrawn out of 649 trials
83.0%
-3.5% vs industry average
13%
85 trials in Phase 3/4
32%
119 of 375 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (649)
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
Role: collaborator
Add-On ZIDA Sock Therapy for Overactive Bladder
Role: collaborator
Sub-Clinical Atrial Fibrillation Biomarker Study
Role: collaborator
Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life
Role: collaborator
Review of the Impact of a Computer-aided Real-time Polyp Detection System on Adult Colonoscopy
Role: collaborator
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy
Role: lead
Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine
Role: collaborator
Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation
Role: collaborator
Minimally Invasive Coronary Artery Bypass Surgery in Patients With Multi Vessel Coronary Disease
Role: collaborator
Glucose Variability in Subclinical Hypertrophy
Role: collaborator
Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation
Role: collaborator
The Boston Pace Study
Role: collaborator
PERIGON Pivotal Trial
Role: collaborator
Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)
Role: collaborator
Lead Evaluation for Defibrillation and Reliability Post Approval Study
Role: lead
Development of Adaptive Deep Brain Stimulation for OCD
Role: collaborator
DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass
Role: collaborator
Arterial Stiffness as a Tool to Investigate Adherence in Resistant Hypertension
Role: collaborator
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
Role: collaborator
Propel Drug-Eluting Sinus Implant Family IBUKI Cohort
Role: lead